We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHD
876
DELISTED
ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE)
AHD
$427K 0.01%
9,111
+411
+5% +$19.3K
AMG icon
877
Affiliated Managers Group
AMG
$9.8B
$426K 0.01%
1,963
+651
+50% +$130K
GLO
878
Clough Global Opportunities Fund
GLO
$260M
$426K 0.01%
32,622
+6,019
+23% +$76.9K
WOOD icon
879
iShares Global Timber & Forestry ETF
WOOD
$273M
$426K 0.01%
8,064
-340
-4% -$17.4K
TEF
880
DELISTED
Telefonica
TEF
$425K 0.01%
35,453
-24,468
-41% -$296K
RXII
881
DELISTED
GALENA BIOPHARMA INC COM
RXII
$421K 0.01%
84,800
+55,800
+192% +$277K
IJJ icon
882
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9B
$420K 0.01%
7,232
+358
+5% +$20.1K
SGL
883
DELISTED
STRATEGIC GLOBAL INCOME FUND
SGL
$420K 0.01%
46,511
+5,136
+12% +$46.5K
MM
884
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$420K 0.01%
57,750
-58,800
-50% -$397K
HQL
885
abrdn Life Sciences Investors
HQL
$627M
$419K 0.01%
20,526
+386
+2% +$7.49K
NFJ
886
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.44B
$419K 0.01%
23,672
-4,000
-14% -$70.7K
VIS icon
887
Vanguard Industrials ETF
VIS
$8.47B
$418K 0.01%
4,174
-317
-7% -$30K
CERN
888
DELISTED
Cerner Corp
CERN
$416K 0.01%
7,480
+280
+4% +$15.7K
IWB icon
889
iShares Russell 1000 ETF
IWB
$50.3B
$415K 0.01%
4,021
+401
+11% +$39.7K
DBC icon
890
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
$414K 0.01%
16,104
-385
-2% -$9.88K
OUTR
891
DELISTED
OUTERWALL INC
OUTR
$413K 0.01%
+6,137
New +$400K
BSV icon
892
Vanguard Short-Term Bond ETF
BSV
$45.6B
$411K 0.01%
5,143
+851
+20% +$68.4K
GOMO
893
DELISTED
SUNGY MOBILE LTD ADS
GOMO
$411K 0.01%
+20,001
New +$334K
FAN icon
894
First Trust Global Wind Energy ETF
FAN
$278M
$410K 0.01%
36,091
+3,639
+11% +$40.1K
CA
895
DELISTED
CA, Inc.
CA
$410K 0.01%
+12,183
New +$387K
PMT
896
PennyMac Mortgage Investment
PMT
$816M
$409K 0.01%
17,833
+362
+2% +$8.19K
WCC
897
WESCO International
WCC
$18.1B
$409K 0.01%
4,491
-45
-1% -$3.75K
CEW
898
WisdomTree Emerging Currency Strategy Fund
CEW
$17.9M
$407K 0.01%
20,302
-865
-4% -$17.5K
JAZZ icon
899
Jazz Pharmaceuticals
JAZZ
$16.6B
$405K 0.01%
3,197
-348
-10% -$36K
H icon
900
Hyatt Hotels
H
$16.1B
$404K 0.01%
8,169
+1,000
+14% +$47.1K

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.